Issue: December 2018
November 09, 2018
2 min watch
Save

Clinician discusses drug penetration technology in Inveltys

Issue: December 2018

SAN ANTONIO – Walter Whitley, OD, MBA, FAAO, discusses the amplified technology behind Inveltys that helps the drug penetrate the eye.

Inveltys (loteprednol etabonate ophthalmic suspension 1%) is a twice-daily ocular steroid for the treatment of inflammation and pain after ocular surgery to be approved by the FDA.